Correlation Between Milestone Pharmaceuticals and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Entrada Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Entrada Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Entrada Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Milestone and Entrada is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Entrada Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.67 times more return on investment than Entrada Therapeutics. However, Milestone Pharmaceuticals is 1.67 times more volatile than Entrada Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.19 per unit of risk. If you would invest 144.00 in Milestone Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Entrada Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Entrada Therapeutics |
Milestone Pharmaceuticals and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Entrada Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Entrada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Entrada Therapeutics vs. Eliem Therapeutics | Entrada Therapeutics vs. HCW Biologics | Entrada Therapeutics vs. Scpharmaceuticals | Entrada Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |